Effects of sumac on inflammatory status, insulin resistance and antioxidant status in metabolic syndrome

Phase 2

Recruiting

Conditions: metabolic syndrome.
Metabolic syndrome
E88.81

Registration Number: IRCT20200106046022N2

Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

Willingness to participate in the study
Adults 20-55 years old
Metabolic syndrome based on modified ATPIII criteria

Exclusion Criteria

Having cardiovascular, liver, kidney, thyroid and diabetes diseases
Pregnancy and lactation
Follow a special diet
Use of drugs that affect appetite, blood pressure, inflammation, fat metabolism and carbohydrates
Use of multivitamin-mineral supplements, fatty acids and herbal remedies

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance (Fasting blood sugar, Insulin, HOMA- IR?QUICKI). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits.;Antioxidant status (MDA,CTL,SOD). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: En Existing commercial kits.;Inflammation status (CRP). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits.

Secondary Outcome Measures

Name	Time	Method
Waist Circumference. Timepoint: At the beginning and end of each intervention period. Method of measurement: Meters irreversible.;Weight. Timepoint: At the beginning and end of each intervention period. Method of measurement: Digital Balance.;BMI. Timepoint: At the beginning and end of each intervention period. Method of measurement: Divide the weight by the square of the height.